SecBot SecBot
6-K ·Filed Nov 4, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 21h ago SEC0001575872-26-000759
Notable filing: 6-K
Actionable Insight • Neutral

The share allotment is routine and immaterial. Monitor next quarterly filing for any acceleration in option exercises that could signal insider sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$14.77
T+0 close · Nov 4, 2026 · via day close
Latest settled
+0.47%
T+5 · $14.84 · next T+20 in 16d
Vs SPY
+1.39%
α at T+5
Latest observation
−0.36%
T+8 · FF3 residual α
  1. T+0 · Nov 4 $14.77entry
  2. T+1 · 12d ago −1.62%α +2.78% · $14.53
  3. T+5 · 6d ago +0.47%α +1.39% · $14.84
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's Laboratories filed a Form 6-K reporting the allotment of 591,270 equity shares to employees upon exercise of stock options under the company's ADR Stock Option Scheme, 2007. This is a routine equity issuance for employee compensation, with no material financial impact or change in business operations.

Key Facts

  • Allotted 591,270 equity shares of Re.1 each on November 4, 2026
  • Shares issued under Dr. Reddy's Employees ADR Stock Option Scheme, 2007
  • Exercise prices ranged from Re.1 to Rs.1,060.20 per share
  • Total issued shares after allotment: 83,527,2555 (including 1,000 forfeited shares)
  • New shares rank pari passu with existing shares

Financial Impact

591,270 shares allotted, representing approximately 0.07% of total issued shares (83.5 million). No material financial impact.

dilution

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
62% bullish (42 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000759
Document: 0001575872-26-000759-index.html0001575872-26-000759
Document: 0001575872-26-000759.txt0001575872-26-000759
Earnings Context (Synthetic; results releases only)0001575872-26-000759

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Viewing Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026